Cannabidivarin (CBDV) May Enhance Immune Response Against Cancer by Targeting Suppressor Cells, Study Finds
- barneyelias0
- Oct 31
- 1 min read
OG article by Anthony Martinelli
October 30 2025
A new study shows promise.
CBDV reprograms suppressor cells in tumors.
These cells block immune attacks.
Results:
Cuts key suppressors: iNOS, Arg-1.
Shifts macrophages to attack mode.
Boosts killer T-cells.
Slows tumors in mice.
Works in human cells.
Impact:
Cancer immunotherapy gets a boost.
Comments